Insider Transactions in Q1 2023 at Eagle Pharmaceuticals, Inc. (EGRX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2023
|
Scott Tarriff |
BUY
Grant, award, or other acquisition
|
Direct |
70,900
+4.14%
|
-
|
|
Mar 01
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
18,500
+27.87%
|
-
|
|
Feb 28
2023
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,113
-0.2%
|
$87,164
$28.0 P/Share
|
|
Feb 28
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
718
-2.39%
|
$20,104
$28.0 P/Share
|
|
Feb 02
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
785
-2.54%
|
$26,690
$34.09 P/Share
|
|
Jan 30
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
601
-1.91%
|
$19,833
$33.21 P/Share
|
|
Jan 23
2023
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,732
-0.24%
|
$123,156
$33.64 P/Share
|
|
Jan 05
2023
|
Scott Tarriff |
SELL
Payment of exercise price or tax liability
|
Direct |
3,827
-0.24%
|
$110,983
$29.26 P/Share
|
|
Jan 05
2023
|
Brian Joseph Cahill CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
734
-2.28%
|
$21,286
$29.26 P/Share
|